{"name": "Tokai Pharmaceuticals",
 "permalink": "tokai-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/tokai-pharmaceuticals",
 "homepage_url": "http://www.tokaipharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "6172254305",
 "description": "hormone-dependent growth disorders",
 "created_at": "Wed Jun 17 21:00:12 UTC 2009",
 "updated_at": "Mon May 27 11:20:17 UTC 2013",
 "overview": "\u003Cp\u003ETokai was founded by Apple Tree Partners to in-license and develop endocrine-based therapies for major diseases.\u003C/p\u003E\n\n\u003Cp\u003EThe company\u00e2\u20ac\u2122s primary focus is on its proprietary Specific Androgen Receptor Modulator/Lyase Inhibitor (TOK-001) for Castration Resistant Prostate Cancer (CRPC).\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[92,
       75],
      "assets/images/resized/0004/9219/49219v1-max-150x150.png"],
     [[92,
       75],
      "assets/images/resized/0004/9219/49219v1-max-250x250.png"],
     [[92,
       75],
      "assets/images/resized/0004/9219/49219v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Jodie",
      "last_name": "Morrison",
      "permalink": "jodie-morrison",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "Seth",
      "last_name": "Harrison",
      "permalink": "seth-harrison",
      "image": null}},
   {"is_past": true,
    "title": "President and CEO",
    "person":
     {"first_name": "Martin",
      "last_name": "D. Williams",
      "permalink": "martin-d-williams",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$100M",
 "funding_rounds":
  [{"round_code": "d",
    "source_url": "http://onbiovc.com/tokai-pharmaceuticals-inc-series-d-22m/",
    "source_description": "Tokai Pharmaceuticals, Inc.: Series D $22M",
    "raised_amount": 22000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 6,
    "funded_day": 9,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Apple Tree Partners",
         "permalink": "apple-tree-partners",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/8810/48810v2-max-150x150.png"],
             [[250,
               35],
              "assets/images/resized/0004/8810/48810v2-max-250x250.png"],
             [[318,
               45],
              "assets/images/resized/0004/8810/48810v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://eon.businesswire.com/news/eon/20110920005655/en",
    "source_description": "Tokai Pharmaceuticals Raises $23 Million in Funding",
    "raised_amount": 23000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 9,
    "funded_day": 20,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Apple Tree Partners",
         "permalink": "apple-tree-partners",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/8810/48810v2-max-150x150.png"],
             [[250,
               35],
              "assets/images/resized/0004/8810/48810v2-max-250x250.png"],
             [[318,
               45],
              "assets/images/resized/0004/8810/48810v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "e",
    "source_url": "http://www.fiercebiotech.com/story/tokai-lands-35m-venture-round-triple-threat-prostate-cancer-drug/2013-05-15?utm_source=rss\u0026utm_medium=rss",
    "source_description": "Tokai lands $35M venture round for triple-threat prostate cancer drug",
    "raised_amount": 35500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Apple Tree Partners",
         "permalink": "apple-tree-partners",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/8810/48810v2-max-150x150.png"],
             [[250,
               35],
              "assets/images/resized/0004/8810/48810v2-max-250x250.png"],
             [[318,
               45],
              "assets/images/resized/0004/8810/48810v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "partial",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1404281/000140428113000001/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 19999993.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 15,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Tokai Pharmaceuticals",
    "address1": "One Broadway",
    "address2": "11th floor",
    "zip_code": "02142",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": 42.362856,
    "longitude": -71.083762}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        80],
       "assets/images/resized/0004/9218/49218v1-max-150x150.png"],
      [[250,
        133],
       "assets/images/resized/0004/9218/49218v1-max-250x250.png"],
      [[450,
        240],
       "assets/images/resized/0004/9218/49218v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}